Hong Kong Pharma Digital Technology Holdings Limited

NasdaqCM:HKPD Stock Report

Market Cap: US$30.3m

Hong Kong Pharma Digital Technology Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lap Sun Wong

Chief executive officer

US$76.7k

Total compensation

CEO salary percentage100.0%
CEO tenureless than a year
CEO ownership57.7%
Management average tenureless than a year
Board average tenureno data

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Lap Sun Wong's remuneration changed compared to Hong Kong Pharma Digital Technology Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024US$77kUS$77k

US$1m

Mar 31 2023US$43kUS$43k

US$998k

Compensation vs Market: Lap Sun's total compensation ($USD76.67K) is below average for companies of similar size in the US market ($USD645.37K).

Compensation vs Earnings: Lap Sun's compensation has increased by more than 20% in the past year.


CEO

Lap Sun Wong (56 yo)

less than a year

Tenure

US$76,668

Compensation

Mr. Lap Sun Wong is Chief Executive Officer and Chairman of the Board of Hong Kong Pharma Digital Technology Holdings Limited since March 2024 and also serves as a Director since August 2023. He founded V-...


Leadership Team

NamePositionTenureCompensationOwnership
Lap Sun Wong
CEO & Chairman of the Boardless than a yearUS$76.67k57.72%
$ 17.5m
Man Bun Kwok
Chief Financial Officerless than a yearno datano data
Yingying Li
Chief Operating Officerless than a yearno datano data

0.8yrs

Average Tenure

44yo

Average Age

Experienced Management: HKPD's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 08:44
End of Day Share Price 2025/01/17 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hong Kong Pharma Digital Technology Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution